Résultats de la recherche

  • Flux RSS
(1 - 20 of 123)

Pages

Addressing the Challenges of Hepatitis C Cure and Persistent Risk of Hepatocellular Carcinoma
Curing chronic hepatitis C--the arc of a medical triumph
Hepatitis C virus co-opts innate immunity component for lipid droplet formation
Overcoming the roadblocks in hepatitis C virus infection
Hepatitis C virus infection and tight junction proteins: The ties that bind.
A first step towards a mouse model for hepatitis C virus infection containing a human immune system
A new HCV mouse model on the block
Viral hepatitis: A new HCV cell culture model for the next clinical challenges
Viral factors and outcome of chronic hepatitis B revisited
Entry inhibitors and future treatment of hepatitis C
Mortality from liver cirrhosis and HCC in the DAA era: success in viral control is darkened by raise of metabolic disease
A bile acid transporter as a candidate receptor for hepatitis B and D virus entry
Modeling the antiviral activity of ribavirin against hepatitis C virus in cell culture
Boceprevir and personalized medicine in hepatitis C virus infection
Status of Direct-Acting Antiviral Therapy for Hepatitis C Virus Infection and Remaining Challenges
Hepatitis C virus entry
Genetically humanized mice recapitulate the entire hepatitis C virus life cycle
Hepatitis B und C: von der molekularen Virologie zu neuen Perspektiven in der Therapie. [Hepatitis B and C: from molecular virology to new antiviral therapies (part 2)]
De la mouche à l'homme - RACK1, un acteur essentiel de la traduction virale dépendante de l'IRES. [From fly to man: RACK1, an essential actor of the dependent viral translation of IRES]
miR-122 acts as a tumor suppressor in hepatocarcinogenesis in vivo.

Pages

Islandora displays